Throughout his time at Eli Lilly, Sidney Taurel maintained a significant stake in the company, demonstrating his belief in its potential. His holdings fluctuated, peaking around 2006 when he had substantial vested stock reflecting a booming company performance. By the...

$47.90M53.84%

Sep 12, 2024

Recent Insider Trades

No insider trades found for this CEO.